<DOC>
	<DOCNO>NCT00704522</DOCNO>
	<brief_summary>Patients receive patient assistance program therapy Hepatitis C enrol study . All patient receive PegIntron pen Rebetol accord label patient assistance program . This study compare similar study clinic use various patient support program purpose design future comparative phase IV study .</brief_summary>
	<brief_title>Adherence Patients Receiving PegIntron Pen/Rebetol Hepatitis C Conjunction With Patient Assistance Program ( Study P04281 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient hepatitis C According product ' labeling ( refer Warnings , contraindication , safety section ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>